Cannistra to edit oncology journal
Stephen A. Cannistra, MD, Director of Gynecological Medical Oncology at BIDMC, will become Editor-in-Chief of The Journal of Clinical Oncology (JCO) effective May 2011.
Having served JCO in various capacities, including reviewer, associate editor, consultant editor and Editorial Board Member since 1989, he will replace Daniel G. Haller, MD, who will complete his second term as Editor-in-Chief of JCO in May 2011.
"I am honored to be named to this position and hope to build on the superb leadership of Dr. Haller," says Cannistra. "I look forward to seeking out ways to maximize our ability to attract the best practice-changing and population-based oncology research and play a greater educational role in the process of clinical investigation."
In addition to his professorship at Harvard Medical School, Cannistra serves as the Co-Leader of the Dana-Farber/Harvard Cancer Center disease program in Gynecologic Oncology.
He has had a longstanding commitment to basic science, clinical investigation and translational research in ovarian cancer, and also plays a major role in medical school and residency education. He has held several leadership positions in ASCO including serving on the Scientific Program Committee as chair of the Gynecologic Cancer subcommittee as well as serving as an ASCO expert on tumor biology.
"We are delighted with the choice of Dr. Cannistra as the next Editor-in-Chief of JCO," says Douglas W. Blayney, MD, President of the American Society of Clinical Oncology (ASCO). "His clinical, research and editorial experience give him insights into the needs of ASCO members and JCO readers that will guide his editorial decisions and allow him to build on the excellence for which the journal is known."